Exercise
EMPERIAL top-line results: Empagliflozin for HFpEF, HFrEF fails to improve exercise ability
Boehringer Ingelheim and Eli Lilly and Co. announced negative top-line results for its EMPERIAL-Reduced and EMPERIAL-Preserved trials, nothing that the SGLT2 inhibitor empagliflozin did not meet the primary endpoint of improvements in exercise ability according to the 6-minute walk test from baseline to 12 weeks compared with placebo in patients with chronic HF with reduced and preserved ejection fraction.
FDA investigates metformin products, and coffee can improve bone health — top stories in endocrinology
Exercise and cardiometabolic health: ‘Never too late to start exercising’
LOS ANGELES — Exercise provides important and varied benefits for individuals with cardiometabolic disorders regardless of experience level, and certain exercise types may yield better outcomes for those with certain conditions, according to a speaker at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease.
High-intensity interval training safe, effective for older adults
Aerobic exercise, not diet, improves diastolic function in type 2 diabetes, obesity
PHILADELPHIA — Adults with type 2 diabetes and obesity without CVD experienced dramatic metabolic improvements after a 12-week, low-calorie diet intervention but saw no change in diastolic function, which was only observed with an aerobic exercise intervention, according to data presented at the American Heart Association Scientific Sessions.
Most adolescents are not physically active enough
Moderate exercise may benefit patients with sickle cell disease
FUEL: Udenafil improves certain exercise performance after Fontan palliation in adolescents
PHILADELPHIA — Udenafil in adolescents after Fontan surgery did not significantly improve oxygen consumption at peak exercise, although it did significantly improve exercise performance at the ventilatory anaerobic threshold, according to data from the FUEL trial presented at the American Heart Association Scientific Sessions.